Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Invasive Cardiology (JIC)
A single-case report describes SAFE-SEAL, a percutaneous bailout technique that restored hemostasis after failure of hybrid femoral closure during transfemoral TAVR, suggesting a potential alternative to more invasive rescue strategies when guidewire access has been lost.
Cardiology October 13th 2026
SLEEP
A systematic review of 30 longitudinal MRI studies found that CPAP therapy in obstructive sleep apnea (OSA) may be associated with structural, functional, vascular, and metabolic brain changes. However, the evidence remains heterogeneous, largely exploratory, and insufficient to support routine MRI monitoring of treatment response.
Neurology September 9th 2026
Medical Professionals Reference (MPR)
The FDA authorized Avulux lenses as a nonpharmacologic adjunct for migraine-associated light sensitivity in patients aged 12 years and older, supported by clinical data showing reduced photophobia and exploratory signals of headache pain improvement in some users.
Neuro-Ophthalmology September 8th 2026
Eyewire+
Alcon has begun the commercial launch of the Unity M surgical microscope, a modular visualization platform designed for anterior and posterior segment surgery that emphasizes enhanced red reflex, color-adjustable illumination, and ophthalmology-specific depth of field.
Ophthalmology September 8th 2026
Brain
Recordings from four Parkinson’s disease patients linked cuneiform and pedunculopontine nuclei activity to distinct phases of gait initiation. Freezing episodes were preceded by disrupted mesencephalic timing, though clinical translation remains early.
Neurology August 5th 2026
Epilepsia
The NAUTILUS trial met its primary safety endpoint for responsive centromedian thalamic stimulation in drug-resistant idiopathic generalized epilepsy. The prespecified primary effectiveness endpoint was not significant, while post hoc and 18-month outcomes showed sustained seizure reductions.